Title:
HEPATITIS B VIRUS-DERIVED POLYPEPTIDE AND ANTI-VIRAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/216603
Kind Code:
A1
Abstract:
A hepatitis B virus-derived polypeptide and a use thereof are provided. A polypeptide according to one aspect exhibits anti-viral effects on HIV-1 and HBV but also on all viruses by increasing the expression of type I interferon, and has a synergistic effect when co-administered with a conventional anti-viral agent, thereby being effectively usable in the treatment of virus-related diseases such as AIDS or liver diseases.
Inventors:
KIM BUM JOON (KR)
CHOI YU MIN (KR)
KIM HONG (KR)
CHOI YU MIN (KR)
KIM HONG (KR)
Application Number:
PCT/KR2019/005302
Publication Date:
November 14, 2019
Filing Date:
May 03, 2019
Export Citation:
Assignee:
SEOUL NAT UNIV R&DB FOUNDATION (KR)
International Classes:
C12N9/12; A61K38/00; A61P31/14; A61P31/20; C07K14/005
Foreign References:
| US20030171538A1 | 2003-09-11 | |||
| KR20100136960A | 2010-12-29 | |||
| KR20120052352A | 2012-05-23 | |||
| KR20120085510A | 2012-08-01 | |||
| EP3189850A1 | 2017-07-12 |
Other References:
CLIN MICROBIOL REV, vol. 14, no. 4, October 2001 (2001-10-01), pages 778 - 809
See also references of EP 3792354A4
See also references of EP 3792354A4
Attorney, Agent or Firm:
Y.P.LEE, MOCK & PARTNERS (KR)
Download PDF: